Would you rather have Joe Veleno or Evgeny Kuznetsov, if you’re the Montreal Canadiens? If the Habs had to add one of the two left-handed centres via free agency this offseason, they made the right decision signing Veleno to a risk-free one-year, $900,000 deal earlier this week.
Obviously, it’s not quite so simple. As a Stanley Cup champion with the Washington Capitals in 2019, Kuznetsov scored a career-high 83 points. He quasi-regularly scored more than 70. Now 33, there’s a small chance he could provide similar secondary scoring in the right situation as he eyes a return to the NHL following a year in the Kontinental Hockey League where he played alongside Ivan Demidov, the Canadiens’ fifth-overall pick in 2024 who joined the Habs at the end of last season.
Demidov has Calder Memorial Trophy potential as an elite-level, albeit-unproven talent. As he’s a 19-year-old Russian acclimating to North America, it’s in the Canadiens’ best interest to make him as comfortable as possible. So, therein lies any hypothetical justification for the Habs to target Kuznetsov to fill the team’s well-documented hole at centre on the second line, where Demidov is likely to play on the wing.
While Veleno is also former first-round pick with similar initial upside, having gone at No. 30 to the Detroit Red Wings in 2018, he’s not a top-six centre, having struggled to produce consistently, to the point the Seattle Kraken, to whom he was traded by the Chicago Blackhawks a few weeks ago, decided to simply buy out the last year of his contract. That obviously facilitated the Canadiens signing him. Veleno being a former client of general manager Kent Hughes may have had a little something to do with it too. If he were a top-six centre, he probably wouldn’t be available at Age 25. If the Canadiens saw him as a top-six centre, they probably wouldn’t have signed him for $900,000 for just a single year. He’s a reclamation project, through and through.
All that having been said, Kuznetsov is far from a top-six-centre lock, himself. With any hypothetical contract, the Canadiens, who are no longer a likely destination for the forward, would have been taking a chance that a) he rediscovers his peak scoring form and b) his widely accepted reputation for having a work-in-progress work ethic is unfounded… and, if it is indeed well-founded, that it wouldn’t rub off on Demidov, on whom the future success of the organization largely depends.
True, by most accounts, Kuznetsov and Demidov displayed chemistry together playing for SKA St. Petersburg last season However, no one knows if that will translate to the NHL. Ultimately, is the small chance that it does worth the risk? With prospect Michael Hage in the pipeline, it wouldn’t have made sense committing to Kuznetsov for more than a single year or two, regardless of his reasonable salarial demands.
Compare and contrast that to Veleno, who again the Canadiens just signed for a single season, after which the now-25-year-old will still be a restricted free agent under team control. Despite it being a one-way deal, the small cap hit isn’t exactly prohibitive to the Habs sending him down to the minors if he isn’t a fit. In such an instance the only real risk would be that another team claims him off waivers. And, if that’s anyone’s primary reservation here, that the Habs could easily lose him, is it worth complaining about, when they didn’t really have to sign him at all?
Veleno serves as little more than an insurance policy. No one saw this signing coming up until the run-up to the point it was being finalized. Few if any were even insinuating the Canadiens had a hole beyond the one at centre on the second line, that Kirby Dach, once he’s healthy again, presumably to start next season, might even be able to fill. That makes Veleno a luxury, not a necessity. However, in contrast to Kuznetsov, he has for all intents and purposes zero propensity to become a liability either.
It’s really just the opposite. If anything, Veleno can surprise to the upside as a 25-year-old, who has only scored a career-high 28 points (2023-24). In contrast, it’s a fairly safe bet Kuznetsov would disappoint, especially if anyone is expecting him to jump back to point-per-game territory.
To be fair, the entire comparison is admittedly disingenuous in that this was never really an either-or situation. It’s not like they struck out on Kuznetsov and signed Veleno as a back-up option. Based on reports, it seems as if it’s the other way around in that the Canadiens couldn’t guarantee Kuznetsov the role he wanted and they then signed Veleno as if to fill a separate one. It just speaks to how illogical one’s mindset can get, were a hypothetical Habs fan to have had their heart set on Kuznetsov only to be disappointed by the Veleno signing. Not for nothing, but the last time Kuznetsov was in the NHL, Veleno outscored the guy (with much less favourable deployment).
As this past season proved, the short-term success of this team doesn’t hinge on a second-line centre. Dach struggled through most of it at the position and the Canadiens still made the playoffs for the first time since 2021. So, while it would certainly be nice were the Habs to acquire one, they don’t need to rush things. They can take their time finding their guy. What’s clear is it’s not Kuznetsov. And it’s probably not Veleno either. That doesn’t mean anyone should close the book on him becoming a valuable player on this team, though (before he’s even played a game for the organization no less). Like the Habs seem to have, open yourself up to all possibilities.
More must-reads:
Get the latest news and rumors, customized to your favorite sports and teams. Emailed daily. Always free!